Skip to main content
OpenTrials
Completed

NCT Number: NCT01146392

An Investigation of the Past 10 Yrs Health Care for Primary Care Patients With Chronic Obstructive Pulmonary Disease

The aim of this study is to describe COPD health care and to assess demographics, concurrent diseases and mortality and the use of pharmaceuticals for a chronic obstructive pulmonary disease (COPD) population in real life in primary care during the last ten years.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD diagnosis according to medical records.
  • Use of drugs prescribed for obstructive lung diseases

Treatment and study plan

Primary outcomes

  1. Describe the development of COPD health care structure in primary care.

    Time frame: Data will be extracted from the medical records on one occassion, covering a period of one decade.

Secondary outcomes

  1. Describe the COPD population in primary care with special reference to treatment, co-morbidity and mortality during last decade.

    Time frame: Data will be extracted from the medical records on one occassion, covering a period of one decade.

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Retrospective Epidemiological Study to Map Out Patients With Chronic Obstructive Pulmonary Disease (COPD) and Describe COPD Health Care in Real-Life Primary Care During the First Ten Years of the 21th Century

Acronym: PATHOS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 17, 2010
Registry last updated
Jun 18, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.